WeedCare - Study on the regulated sale of cannabis in pharmacies in Canton Basel-Stadt

The WEED CARE study is examining the effects in public health terms of permitting regulated cannabis sales, compared to the present situation in which cannabis is illegal.

The resulting scientific findings will provide a basis for discussion on a future responsible cannabis policy in Switzerland.

Responsible organisation(s)

• Abteilung Sucht, Gesundheitsdepartement Basel-Stadt (Commissioning organisation), www.sucht.bs.ch
  
• Universitäre Psychiatrische Kliniken Basel (institution conducting the study), www.upk.ch
  
• Universität Basel (institution conducting the study), www.dkf.unibas.ch
  

• Regine Steinauer (Contact)
  Abteilung Sucht
  Malzgasse 30
  4001 Basel
  [e-mail] / 061 267 89 00

Canton(s)

BS

Commune(s)

City of Basel

Planned duration of the study

until March 2025

Points of sale

Pharmacies

Study type

• Randomised controlled trial (RCT)
• Observational study
  

Sample size

• Experimental group n1 = 187
• Control group n4 = 187
• Total sample size N = 374

Funder

• Canton Basel-Stadt (funds)
• Addictions Section, Canton Basel-Stadt Department of Health (services)
• University Psychiatric Clinics Basel (services)
• Psychiatrische Dienste Aargau AG (services)

Links

• https://weedcare-basel.ch/
• Weed Care – Forschung zur Regulierung des Cannabiskonsums – DKF Basel
• https://www.kofam.ch/en/snctp-portal/searching-for-a-clinical-trial/study/58583

Last modification 23.11.2023